Pharmacokinetics and Safety of 'CG-745 IV' and 'CG-750' in Healthy Male Adults
Clinical trial NCT05345912 · COMPLETED
Trial details
- NCT number
- NCT05345912
- Sponsor
- CrystalGenomics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-16
- Primary completion
- 2020-09-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.